Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Neuropharmacology is Scopus-indexed (Q1, CiteScore 11.4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1570-159XVerify ISSN ↗1875-6190Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Psychiatry and Mental Health | 29 / 580 | 95th | Q1 |
| Pharmacology (medical) | 17 / 278 | 94th | Q1 |
| Neurology (clinical) | 27 / 403 | 93rd | Q1 |
| Neurology | 14 / 201 | 93rd | Q1 |
| Pharmacology | 31 / 328 | 90th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q1, CiteScore 11.4.
Current Neuropharmacology is Q1 in Psychiatry and Mental Health (rank 29 of 580), Q1 in Pharmacology (medical) (rank 17 of 278) and Q1 in Neurology (clinical) (rank 27 of 403), by CiteScore 2025. It is ranked in 5 subject areas in all.
Current Neuropharmacology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.4, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.642, quartile Q1, with an H-index of 125.
Current Neuropharmacology is published by Bentham Science Publishers. Its print ISSN is 1570-159X and its online ISSN is 1875-6190.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Neuropharmacology has an h-index of 140 and a 2-year mean of 2.74 citations per paper (OpenAlex). Its Scopus CiteScore is 11.4, quartile Q1. On 2-year citations it ranks #134 of 570 Scopus journals in Psychiatry and Mental Health.
Current Neuropharmacology published 184 papers in 2025; its busiest recent year was 2021 with 228. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (50.2%), United States (5.5%) and India (5.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.